CDC offers rules for using preventive Truvada
The U.S. Centers for Disease Control and Prevention issued some interim guidance on how physicians should actually use Gilead Sciences' HIV drug Truvada as a preventive drug. Report
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Latest Commentary
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What’s your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- New York Genome Center Announces Formal Commencement of Collaborative Relationship with Illumina
- Baxano Completes Enrollment in Lumbar Spinal Stenosis Study
- PRA Expands Operations in Europe
- New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
- Greatbatch to Establish New Global Headquarters
- More Press Releases
Featured Jobs
-
Director, Public Relations Job
Celgene Corporation - Summit, NJ, US -
Microbiology Scientist
C3 Jian - Marina Del Rey, CA -
Director, Regulatory Affairs
Tesaro - Waltham, MA -
Biostatistician (Entry Level) - Permanent Job
Yoh - Tarrytown, NY, USA -
Clinical Trial Manager
TESARO - Waltham, MA
Comments